Which statement best describes how to address poly-substance use in treatment planning?

• A. Assess patterns, interactions, withdrawal risks, and tailor integrated treatment strategies.
• B. Treat each substance in isolation.
• C. Ignore withdrawal risks.
• D. Assume all substances are equally impacted.

Answer: (C)

Polysubstance use requires an integrated assessment and plan that considers how multiple substances interact and influence treatment needs. Start with a thorough look at usage patterns (which substances, amounts, routes, and timing), how those substances interact with one another, and the withdrawal risks for each substance. This helps identify potential compounded withdrawal syndromes and safety concerns, which is crucial for planning detox, medication decisions, and monitoring.

From there, tailor an integrated treatment strategy that addresses all substances together, rather than in a vacuum. Coordinating pharmacotherapy, behavioral therapies, and support services across substances reduces the risk of adverse interactions, supports safer detox if needed, and aligns goals for recovery. This integrated approach also helps manage co-occurring mental health issues and social factors that can influence use across substances.

Why mixing in a single-substance focus isn’t ideal: treating each substance separately can miss important interactions, leading to incomplete safety planning and contradictory goals. Ignoring withdrawal risks can result in dangerous complications or relapse. And assuming all substances are affected equally ignores the distinct withdrawal timelines, symptom profiles, and treatment needs of different substances, which can undermine outcomes.